🌍 NLS Pharmaceutics Ltd. (NLSPW) - Form 6-K Filing
Filing Date: 2025-10-28
Accepted: 2025-10-28 16:37:59
Event Type: Clinical Trial Update
Event Details:
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction. Closing of the Merger has been set for Oct 28, 2025. Nasdaq approval for the listing of the Companys common shares and the trading of the Company.
💼 Business Developments:
✅ Partnership/Collaboration
❌ Acquisition Activity: Not reported
❌ Licensing Agreement: Not reported
✅ Regulatory Milestone
❌ Leadership Updates: Not reported
📞 Contact Information:
Media Contact: s NLS Contacts: InvestorRelations@nls-pharma.com www.nlspharma.com Kadimastem Co
🌍 NLS Pharmaceutics Ltd. (NLSPW) - Form 6-K Filing
Filing Date: 2025-10-28
Accepted: 2025-10-28 16:37:59
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: